Wird geladen...
Targeting the adaptive molecular landscape of castration-resistant prostate cancer
Castration and androgen receptor (AR) pathway inhibitors induce profound and sustained responses in advanced prostate cancer. However, the inevitable recurrence is associated with reactivation of the AR and progression to a more aggressive phenotype termed castration-resistant prostate cancer (CRPC)...
Gespeichert in:
| Veröffentlicht in: | EMBO Mol Med |
|---|---|
| Hauptverfasser: | , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley & Sons, Ltd
2015
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4520654/ https://ncbi.nlm.nih.gov/pubmed/25896606 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/emmm.201303701 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|